A Agilent Technologies, Inc.
Healthcare
Price
$149.24
Intrinsic value
$28.76
Buy price
$23.01
Discount
-419.0%
DCF walkthrough
Near-term growth (g1)0.00%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $1,452,000,000.00
- Total debt
- $3,542,000,128.00
- Cash & STI
- $1,807,000,064.00
- Shares out.
- 283,000,000
Overvalued
Intrinsic value$28.76
Buy price (with MOS)$23.01
Current price$149.24
Discount to intrinsic value-419.0%
7-step quality scorecard
ROE quality
HIGH_CONSISTENT- Average ROE
- 21.5%
- Current ROE
- 19.3%
- Minimum ROE
- 19.3%
Debt quality
MODERATE- Debt / Equity
- 0.53x
Moat proxy
STRONG_PROXYCash-flow reliability
OK- Operating CF / Net income
- 1.03x
Technical chart
Confluence: NONE (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(cfCAGR,revenueCAGR)+decel_adj
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 35.9%
- Public economic interest
- 100.0%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.